APA (7th ed.) Citation

Ashton, N. J., Leuzy, A., Karikari, T. K., Mattsson-Carlgren, N., Dodich, A., Boccardi, M., . . . Hansson, O. (2021). The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers. European Journal of Nuclear Medicine & Molecular Imaging, 48(7), 2140. https://doi.org/10.1007/s00259-021-05253-y

Chicago Style (17th ed.) Citation

Ashton, N. J., et al. "The Validation Status of Blood Biomarkers of Amyloid and Phospho-tau Assessed with the 5-phase Development Framework for AD Biomarkers." European Journal of Nuclear Medicine & Molecular Imaging 48, no. 7 (2021): 2140. https://doi.org/10.1007/s00259-021-05253-y.

MLA (9th ed.) Citation

Ashton, N. J., et al. "The Validation Status of Blood Biomarkers of Amyloid and Phospho-tau Assessed with the 5-phase Development Framework for AD Biomarkers." European Journal of Nuclear Medicine & Molecular Imaging, vol. 48, no. 7, 2021, p. 2140, https://doi.org/10.1007/s00259-021-05253-y.